Orion Pharma’s Q3 earnings rises

The third quarterly (January-March) earnings of Orion Pharma rose by 55.73 percent. 

In a filing with Dhaka Stock Exchange on Monday, the company said that its consolidated earnings per share (EPS) was Tk 0.95 for January-March 2021 as against Tk 0.61 for the same period of the previous financial year. 

Meanwhile, its consolidated net asset value (NAV) per share excluding revaluation surplus was Tk 70.79 as of March 31, 2021 and Tk 68.69 as of June 31, 2020. 

Including revaluation surplus, the net asset value (NAV) per share was Tk 78.78 as of March 31, 2021, and Tk 76.77 as of June 31, 2020. 

Orion Pharma made its debut on Dhaka Stock Exchange on March 20, 2013. The company offered 10 percent cash dividend to its shareholders for the year 2020. 

The adjusted opening price for each of its shares was Tk 53.9 during Monday’s session.